Status:
COMPLETED
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Clinical Trials in Organ Transplantation
Conditions:
Liver Transplantation
Eligibility:
All Genders
Brief Summary
Acute cellular rejection is relatively common after liver transplantation, typically does not affect graft survival, and is not associated with the development of chronic rejection. Acute cellular rej...
Eligibility Criteria
Inclusion
- Specimens derived from subjects enrolled in the ITN030ST study.
- Availability of adequate biopsy specimens with corresponding blood and/or serum collected within a 10 day window of a for-cause or protocol biopsy.
Exclusion
- Withdrawal of consent for the ITN030ST study.
- Absence of consent in the ITN030ST study for the collection and storage of samples of blood and tissue for future research studies.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT01428700
Start Date
August 1 2011
End Date
January 1 2013
Last Update
March 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.